The global Irritable Bowel Syndrome Treatment Market was valued at USD 1.47 billion in 2022 and is projected to reach USD 2.81 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030, according to the latest market analysis.
Irritable Bowel Syndrome (IBS) Treatment Market Report. This handy little document is chock full of information on all the...
Pragma Market Research and Business Consulting has published a new study titled "IBS-C Drug Market: Size, Trends, and Insights" covering the market's dimensions, trends, and insights.
Market Overview
“According to the latest research study, the demand of global IBS-C Drug Market size & share was valued at approximately US$ XX million in 2023 and is expected to reach US$ XX million in...
SNS Insider reports that the global chlamydia infection treatment market was valued at USD 3.83 billion in 2023 and is forecasted to reach USD 8.09 billion by 2031. This growth represents a compound annual growth rate (CAGR) of 9.81% during the forecast period from 2024 to 2031.
The Irritable Bowel Syndrome (IBS) Treatment Market, valued at USD 1.47 billion in 2022, is projected to...
Irritable Bowel Syndrome (IBS) Treatment Market business insights
The global Irritable Bowel Syndrome (IBS) Treatment Market , valued at USD 1.47 billion in 2022, is anticipated to expand significantly, reaching USD 2.81 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 8.4% during the forecast period from 2023 to 2030.
Market Overview
Irritable...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian